```html

Radiation Enteritis – Comprehensive Medical Guide

Overview

Radiation enteritis (also called radiation‑induced enteritis) is inflammation of the small intestine that occurs after exposure to therapeutic radiation. The condition can be acute (developing during or within 6 weeks of radiation) or chronic (persisting or appearing months to years later). It most commonly affects patients receiving radiation for abdominal or pelvic cancers such as:

• Colorectal cancer
• Prostate cancer
• Cervical and uterine cancers
• Bladder cancer
• Gastric and pancreatic tumors

According to the American Cancer Society, up to 30 % of patients undergoing pelvic radiation develop some degree of enteritis, and 5‑15 % experience clinically significant chronic disease that interferes with quality of life.

Symptoms

Symptoms may appear during treatment (acute) or months to years later (chronic). They can range from mild to severe.

Acute Radiation Enteritis

• Abdominal cramping – typically colicky, worsening after meals.
• Diarrhea – watery, may be frequent (≥3 stools/day).
• Nausea & vomiting – especially if the duodenum is involved.
• Urgent bowel movements – a sense of incomplete evacuation.
• Loss of appetite – due to discomfort or nausea.
• Low‑grade fever – can signal inflammation.

Chronic Radiation Enteritis

• Persistent diarrhea – may be watery or fatty (steatorrhea).
• Abdominal pain or bloating – often post‑prandial.
• Weight loss – from malabsorption and reduced intake.
• Fatigue – secondary to anemia, dehydration, or nutrient deficiencies.
• Blood in stool – indicates ulceration or bleeding.
• Nutrient deficiencies – especially vitamin B12, iron, calcium, and fat‑soluble vitamins.
• Intestinal obstruction – due to strictures or adhesions (see Complications).

Causes and Risk Factors

Radiation damages the rapidly dividing cells that line the intestinal mucosa. The injury progresses through three phases:

1. Direct DNA damage to epithelial cells.
2. Inflammatory cascade – cytokines, free radicals, and vascular injury.
3. Fibrosis and stricture formation (chronic phase).

Key Risk Factors

• Radiation dose & volume – Doses >45 Gy to a large segment of the small bowel raise risk dramatically.
• Treatment technique – Older 2‑D or 3‑D conformal plans expose more normal tissue than modern intensity‑modulated radiotherapy (IMRT) or proton therapy.
• Concurrent chemotherapy – Agents such as 5‑fluorouracil, capecitabine, or oxaliplatin sensitize the gut to radiation.
• Previous abdominal surgery – Adhesions may place loops of bowel within the radiation field.
• Pre‑existing inflammatory bowel disease (IBD) – Increases susceptibility.
• Smoking and poor nutrition – Impair mucosal healing.

Diagnosis

Diagnosing radiation enteritis relies on correlating clinical history with imaging and endoscopic findings while excluding infection or disease recurrence.

Clinical Assessment

• Detailed treatment history (dose, fields, chemotherapy).
• Symptom chronology (acute vs. chronic).
• Physical exam – abdominal tenderness, signs of dehydration, or palpable masses.

Laboratory Tests

• Complete blood count – anemia, leukocytosis.
• Electrolytes & renal function – assess dehydration.
• Stool studies – rule out infection (Clostridioides difficile, parasites).
• Vitamin & mineral panels – B12, iron, folate, calcium, vitamin D.

Imaging & Endoscopy

• CT abdomen/pelvis with contrast – reveals wall thickening, edema, or strictures.
• MRI enterography – superior soft‑tissue detail, useful for chronic fibrosis.
• Capsule endoscopy – visualizes mucosal injury throughout the small bowel; avoid if obstruction suspected.
• Double‑balloon enteroscopy – allows biopsy and therapeutic interventions.
• Barium studies – classic “string sign” or ulcerated segments in chronic disease.

Biopsy

Histology shows crypt loss, inflammatory infiltrates, and later, fibrosis. Biopsy is especially important to exclude recurrent tumor or infection.

Treatment Options

Treatment is individualized, targeting symptom relief, mucosal healing, and preventing complications.

Acute Management

• Fluid & electrolyte replacement – oral rehydration solutions or IV fluids for severe dehydration.
• Antidiarrheal agents – Loperamide (Imodium) 2 mg after each loose stool (max 16 mg/day). For refractory cases, diphenoxylate‑atropine (Lomotil) may be used.
• Antiemetics – Ondansetron 4–8 mg PO/IV q8h.
• Probiotics – Evidence from a 2021 meta‑analysis (Cochrane) suggests modest benefit in reducing diarrhea severity.
• Nutrition – Low‑residue, low‑fat diet; consider short‑term total parenteral nutrition (TPN) if oral intake is impossible.

Chronic Management

1. Dietary modifications
   • Small, frequent meals; avoid high‑fiber, high‑fat, and gas‑producing foods.
   • Supplement medium‑chain triglyceride (MCT) oil if fat malabsorption is present.
   • Consider low‑FODMAP diet to reduce bloating.
2. Medications
   • Anti‑inflammatory agents: Budesonide (Entocort) 9 mg daily for up to 8 weeks can reduce mucosal inflammation.
   • Antibiotics: Rifaximin 550 mg BID for 2 weeks may help bacterial overgrowth.
   • Octreotide (Somatuline) 50‑100 µg SC q8h for severe refractory diarrhea.
   • Supplementation*: B12 (1000 µg IM monthly), iron, calcium, vitamin D, and multivitamins.
3. Endoscopic or Surgical Interventions
   • Endoscopic dilation of strictures.
   • Fistula repair or segmental small‑bowel resection for obstructive disease.
4. Hyperbaric Oxygen Therapy (HBOT)

   Several small trials (e.g., Houston et al., 2020, Radiotherapy Oncology) show HBOT can promote mucosal healing and reduce pain, though availability is limited.

Adjunctive Therapies

• Psychological support – chronic GI symptoms often cause anxiety and depression.
• Physical activity – gentle walking improves gut motility.

Living with Radiation Enteritis

Effective self‑management empowers patients to maintain nutrition, avoid dehydration, and minimize flare‑ups.

Practical Daily Tips

• Hydration: Aim for 2–3 L of water or oral rehydration solution daily; add a pinch of salt and a teaspoon of sugar if diarrhea is frequent.
• Meal planning: Cooked vegetables (carrots, zucchini), lean proteins (chicken, fish), and refined grains (white rice, plain pasta) are usually well tolerated.
• Record keeping: Keep a symptom diary noting foods, bowel patterns, and medication timings. This helps identify triggers.
• Medication adherence: Set alarms for antidiarrheal or supplement doses.
• Regular follow‑up: Schedule gastroenterology visits every 3–6 months, or sooner if symptoms change.
• Vaccinations: If on immunosuppressive meds (e.g., steroids), keep flu and pneumococcal vaccines up‑to‑date.

Psychosocial Strategies

• Join support groups (e.g., CancerCare, local IBD groups).
• Mind‑body techniques – meditation, guided breathing, or yoga can mitigate stress‑related GI symptoms.
• Seek counseling if chronic illness triggers depression or anxiety.

Prevention

While radiation itself cannot be avoided in cancer treatment, several strategies reduce the likelihood or severity of enteritis.

• Modern radiation techniques – IMRT, image‑guided radiotherapy (IGRT), and proton therapy spare more normal bowel.
• Motion management – Breath‑hold or gating methods limit bowel exposure during pelvic treatment.
• Protective agents – Amifostine (a radioprotective drug) has shown modest benefit in decreasing acute GI toxicity (NIH, 2019).
• Pre‑treatment nutrition – Optimizing albumin and micronutrient levels improves mucosal resilience.
• Smoking cessation & alcohol moderation – Reduces oxidative stress and improves healing.
• Prophylactic probiotics – Some institutions give Lactobacillus‑containing formulations during pelvic radiation; data are mixed but safety is high.

Complications

If left untreated, radiation enteritis can lead to serious health problems:

• Severe dehydration & electrolyte imbalance – May cause cardiac arrhythmias.
• Malnutrition & weight loss – Impairs immune function and cancer recovery.
• Chronic anemia – From iron or B12 deficiency.
• Intestinal obstruction – Fibrotic strictures can block the lumen, requiring emergency surgery.
• Fistula formation – Abnormal connections between bowel and bladder, vagina, or skin.
• Secondary infections – Mucosal breaks can permit bacterial translocation.
• Increased risk of secondary malignancy – Long‑term data show a small rise in small‑bowel adenocarcinoma after high‑dose pelvic radiation (JAMA Oncology, 2022).

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:

• Sudden, severe abdominal pain or cramping that does not improve with usual pain meds.
• Vomiting that is green, bloody, or persistent (more than 2‑3 times).
• Signs of dehydration: dizziness, fainting, rapid heartbeat, dry mouth, or urine that is dark yellow/amber.
• High fever (≥38.5 °C / 101.3 °F) with chills.
• Visible blood in stool or black/tarry stools (possible gastrointestinal bleeding).
• Inability to pass gas or have a bowel movement – possible bowel obstruction.
• Severe, unexplained weight loss (>10 % body weight in a month) or weakness.

---

Radiation enteritis can be a challenging side effect of life‑saving cancer therapy, but with timely diagnosis, proactive treatment, and lifestyle adjustments most patients achieve good symptom control and maintain nutrition. Always discuss any new or worsening gastrointestinal symptoms with your oncology or gastroenterology team promptly.

References:

• Mayo Clinic. “Radiation enteritis.” Accessed March 2024.
• Cleveland Clinic. “Radiation-induced bowel injury.” 2023.
• National Cancer Institute. “Radiation Therapy Side Effects.” Updated 2022.
• Houston, K. et al. “Hyperbaric oxygen therapy for chronic radiation enteritis.” Radiotherapy & Oncology, 2020.
• JAMA Oncology. “Long‑term risk of secondary small‑bowel cancer after pelvic radiation.” 2022.
• World Health Organization. “Guidelines for the Safe Use of Radiotherapy.” 2021.

```